Europe Metagenomics Market to 2027 - Regional Analysis and Forecasts by Product (Instruments & Software and Consumables), Application (Clinical Diagnostics, Drug Discovery Metagenomics and Others) and Country
Publication Month: Feb 2019
Report Code: TIPRE00003321 No. of Pages: 138 Category: Biotechnology Status: Published
The Europe Metagenomics market is expected to reach US$ 89.7 Mn in 2027 from US$ 48.6 Mn in 2018. The market is estimated to grow with a CAGR of 7.4% from 2018-2027.
The growth of the market is driven by the factors such as technological advancements in the metagenomics, growing preference for Metagenomics over traditional methods and wide range metagenomics applications, in the Europe region. Whereas, highly priced metagenomics technology is likely to have a negative impact on the growth of the market in the coming years.
Metagenomics is the upcoming field of the biotechnology and the extensive researches are being conducted in the labs across the world. In addition, the next generation sequencing and other technologies in the genomics are assisting in the conduction of the metagenomics studies. Also, in recent years, next generation sequencing price have declined substantially. For instance, first whole human genome sequencing cost over US$3.7 billion in 2000 and took 13 years for the completion. However, the costs for the same in recent years has reduced to US$1,000 and the process requires less number of days. In 2000, cost for sequencing was US$ 3.7 billion, which dropped down to US$ 10 million in 2006 and declined to US$ 5,000 in 2012. One of the few biotech unicorns in Europe, Oxford Nanopore Technologies based in UK have introduced breakthrough technologies in DNA sequencing. The company has developed handheld MinION sequencer to sequence the human genome. The device was able to read sequences of DNA that are hundreds times larger than usual, helping scientists better reconstruct the whole genome sequence. MinION costs less than $1,000 and offers high-speed sequencing even outside of the lab, with an accuracy of up to 99.96% when using ‘nanopolish’ software to correct any errors made during sequencing.
Owing to factor that the cost of the metagenomics is been subsidize by the venture capitalists and the innovative technology by the market leaders that enables the access to the metagenomics studies are likely to propel the growth of the market in the forecast period.
Germany is measured as the biggest hub for biotechnology in Europe and across the world owing to presence of large biotechnology players, high-tech research labs and massive funding for conduction of research and development. Germany is a country where various biotechnological companies reside than any other countries in Europe. The country is also accounted in the international list of toppers for the number of studies that are in pipeline. The cutting edge and high-quality research present in the country creates lucrative opportunity and presence of an established market for metagenomics.
EUROPE METAGENOMICS - MARKET SEGMENTATION
By Product
By Application
The growth of the market is driven by the factors such as technological advancements in the metagenomics, growing preference for Metagenomics over traditional methods and wide range metagenomics applications, in the Europe region. Whereas, highly priced metagenomics technology is likely to have a negative impact on the growth of the market in the coming years.
Metagenomics is the upcoming field of the biotechnology and the extensive researches are being conducted in the labs across the world. In addition, the next generation sequencing and other technologies in the genomics are assisting in the conduction of the metagenomics studies. Also, in recent years, next generation sequencing price have declined substantially. For instance, first whole human genome sequencing cost over US$3.7 billion in 2000 and took 13 years for the completion. However, the costs for the same in recent years has reduced to US$1,000 and the process requires less number of days. In 2000, cost for sequencing was US$ 3.7 billion, which dropped down to US$ 10 million in 2006 and declined to US$ 5,000 in 2012. One of the few biotech unicorns in Europe, Oxford Nanopore Technologies based in UK have introduced breakthrough technologies in DNA sequencing. The company has developed handheld MinION sequencer to sequence the human genome. The device was able to read sequences of DNA that are hundreds times larger than usual, helping scientists better reconstruct the whole genome sequence. MinION costs less than $1,000 and offers high-speed sequencing even outside of the lab, with an accuracy of up to 99.96% when using ‘nanopolish’ software to correct any errors made during sequencing.
Owing to factor that the cost of the metagenomics is been subsidize by the venture capitalists and the innovative technology by the market leaders that enables the access to the metagenomics studies are likely to propel the growth of the market in the forecast period.
Germany is measured as the biggest hub for biotechnology in Europe and across the world owing to presence of large biotechnology players, high-tech research labs and massive funding for conduction of research and development. Germany is a country where various biotechnological companies reside than any other countries in Europe. The country is also accounted in the international list of toppers for the number of studies that are in pipeline. The cutting edge and high-quality research present in the country creates lucrative opportunity and presence of an established market for metagenomics.
Exhibit: Rest of Europe Metagenomics Market Revenue and Forecasts to 2027 (US$ Bn)
EUROPE METAGENOMICS - MARKET SEGMENTATION
By Product
- Instruments & Software
- Consumables
By Application
- Clinical Diagnostics
- Drug Discovery
- France
- Germany
- U.K.
- Merck KGaA
- Thermo Fisher Scientific Inc.
- Agilent Technologies
- Qiagen
- Bio-Rad Laboratories, Inc.
- Perkinelmer Inc.
- Illumina Inc.
- F Hoffman-La Roche Ltd.
- Oxford Nanopore Technologies Ltd.
- Pacific Bioscience of California, Inc.
PART 1. iNTRODUCTION
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
PART 2. Europe Metagenomics Market – Key takeaways
PART 3. Europe Metagenomics market – market landscape
3.1 overview
3.2 market segmentation
3.2.1 Europe Metagenomics Market – By Product
3.2.2 Europe Metagenomics Market – By Application
3.2.3 Europe Metagenomics Market – By Country
3.3 PEST Analysis
PART 4. Europe Metagenomics market- Key Market Dynamics
4.1 Key Market Drivers
4.1.1 Technological Advancements in Metagenomics
4.1.2 Growing Preference for Metagenomics Over Traditional Methods
4.1.3 Wide Range of Metagenomics Applications
4.2 Key Market Restraints
4.2.1 Highly Priced Metagenomics Technology
4.3 Key Market Opportunities
4.3.1 Precision Metagenomic Analysis- Ushering In The Era Of Precision Medicine
4.4 Key Market Trends
4.4.1 Increasing Inclination towards Molecular-Based Approaches
4.5 Impact analysis
PART 5. Metagenomics market – Europe Analysis
5.1 Europe Metagenomics market Revenue Forecasts and Analysis
5.2 Market positioning
5.3 PERFORMANCE OF KEY PLAYERS
Illumina, Inc.
Qiagen
5.4 expert opinions
PART 6. Europe Metagenomics market Analysis – By Product
6.1 Overview
6.2 EUROPE metagenomics MARKET, BY product, 2018 & 2027 (%)
6.3 Europe Metagenomics market Revenue And Forecasts to 2027, By Product (US$ Mn)
6.4 Instruments & Software Market
6.4.1 Overview
6.4.2 Europe Instruments & Software Market Revenue and Forecasts to 2027 (US$ Mn)
6.5 Consumables Market
6.5.1 Overview
6.5.2 Europe Consumables Market Revenue and Forecasts to 2027 (US$ Mn)
PART 7. Europe Metagenomics market Analysis – By Application
7.1 Overview
7.2 EUROPE Metagenomics MARKET, BY application, 2018 & 2027 (%)
7.3 Europe Metagenomics market Revenue And Forecasts to 2027, By Application (US$ Mn)
7.4 Clinical Diagnostic Market
7.4.1 Overview
7.4.2 Europe Clinical Diagnostic Market Revenue and Forecasts to 2027 (US$ Mn)
7.5 Drug Discovery metagenomics Market
7.5.1 Overview
7.5.2 Europe Drug Discovery Metagenomics Market Revenue and Forecasts to 2027 (US$ Mn)
7.6 Others Market
7.6.1 Overview
7.6.2 Europe Others Market Revenue and Forecasts to 2027 (US$ Mn)
PART 8. Europe Metagenomics market Revenue and Forecasts to 2027
8.1 Overview
8.2 Europe Metagenomics Market Revenue And Forecasts to 2027, By Country (%)
8.3 UK Metagenomics market Revenue and Forecasts to 2027 (US$ Mn)
8.3.1 UK Metagenomics Market Revenue and Forecasts to 2027 (US$ Mn)
8.3.2 UK Metagenomics Market Revenue And Forecasts to 2027, By Product (US$ Mn)
8.3.3 UK Metagenomics Market Revenue And Forecasts to 2027, By Application (US$ Mn)
8.4 Germany Metagenomics market Revenue and Forecasts to 2027 (US$ Mn)
8.4.1 Germany Metagenomics Market Revenue and Forecasts to 2027 (US$ Mn)
8.4.2 Germany Metagenomics Market Revenue And Forecasts to 2027, By Product (US$ Mn)
8.4.3 Germany Metagenomics Market Revenue And Forecasts to 2027, By Application (US$ Mn)
8.5 France Metagenomics market Revenue and Forecasts to 2027 (US$ Mn)
8.5.1 France Metagenomics Market Revenue and Forecasts to 2027 (US$ Mn)
8.5.2 France Metagenomics Market Revenue And Forecasts to 2027, By Product (US$ Mn)
8.5.3 France Metagenomics Market Revenue And Forecasts to 2027, By Application (US$ Mn)
PART 9. Metagenomics Market –Industry Landscape
9.1 Overview
9.2 Growth Strategies in the Metagenomics Market, 2015-2018
9.3 Organic Developments
9.3.1 Overview
9.4 Organic Growth Strategies in the METAGENOMICS Market, 2015-2018
9.5 Product Launch
9.5.1 Recent Product Launch By Players In The Metagenomics Market
9.6 Product approval
9.6.1 Recent Product Approval By Players In The Metagenomics Market
9.7 Expansion & Others
9.7.1 The Metagenomics Market By Expansion & Other Growth Strategies
9.8 Inorganic developments
9.8.1 Overview
9.9 inOrganic Growth Strategies in the Metagenomics Market, 2015-2018
9.10 Acquisitions
9.10.1 Acquisitions By Players In The Metagenomics Market
9.11 Agreements
9.11.1 The Metagenomics Market By Agreements
9.12 Partnership & Collaboration
9.12.1 Partnership By Players In The Metagenomics Market
PART 10. Metagenomics Market–Key company profiles
10.1 Merck KGaA
10.1.1 Key Facts
10.1.2 Business Description
10.1.3 Financial Overview
10.1.4 Product Portfolio
10.1.5 SWOT Analysis
10.1.6 Key Developments
10.2 Thermo Fisher Scientific, Inc.
10.2.1 Key Facts
10.2.2 Business Description
10.2.3 Financial Information
10.2.4 Product Portfolio
10.2.5 SWOT Analysis
10.2.6 Key Developments
10.3 Agilent Technologies, Inc.
10.3.1 Key Facts
10.3.2 Business Description
10.3.3 Financial Overview
10.3.4 Product Portfolio
10.3.5 SWOT Analysis
10.3.6 Key Developments
10.4 QIAGEN
10.4.1 Key Facts
10.4.2 Business Description
10.4.3 Financial Overview
10.4.4 Product Portfolio
10.4.5 SWOT Analysis
10.4.6 Key Developments
10.5 Bio-Rad Laboratories, Inc.
10.5.1 Key Facts
10.5.2 Business Description
10.5.3 Financial Information
10.5.4 Product Portfolio
10.5.5 SWOT Analysis
10.5.6 Key Developments
10.6 Perkin Elmer, inc.
10.6.1 Key Facts
10.6.2 Business Description
10.6.3 Financial Overview
10.6.4 Product Portfolio
10.6.5 SWOT Analysis
10.6.6 Key Developments
10.7 Illumina, Inc.
10.7.1 Key Facts
10.7.2 Business Description
10.7.3 Financial Overview
10.7.4 Product Portfolio
10.7.5 SWOT Analysis
10.7.6 Key Developments
10.8 F. Hoffmann-La Roche Ltd.
10.8.1 Key Facts
10.8.2 Business Description
10.8.3 Financial Overview
10.8.4 Product Portfolio
10.8.5 SWOT Analysis
10.8.6 Key Developments
10.9 Oxford Nanopore Technologies Ltd.
10.9.1 Key Facts
10.9.2 Business Description
10.9.3 Financial Overview
10.9.4 Product & Services Portfolio
10.9.5 SWOT Analysis
10.9.6 Key Developments
10.10 Pacific Bioscience of California, inc.
10.10.1 Key Facts
10.10.2 Business Description
10.10.3 Financial Overview
10.10.4 Product & Services Portfolio
10.10.5 SWOT Analysis
10.10.6 Key Developments
PART 11. Appendix
11.1 About The Insight Partners
11.2 Glossary of Terms
11.3 Methodology
11.3.1 Coverage
11.3.2 Secondary Research
11.3.3 Primary Research
LIST OF TABLES
TABLE 1. Europe Metagenomics market Revenue And Forecasts to 2025, By product (US$ Mn)
TABLE 2. Europe Metagenomics market Revenue And Forecasts to 2025, By application (US$ Mn)
TABLE 3. UK Metagenomics market Revenue And Forecasts to 2027, By Product (US$ Mn)
TABLE 4. UK Metagenomics market Revenue And Forecasts to 2025, By application (US$ Mn)
TABLE 5. Germany Metagenomics market Revenue And Forecasts to 2027, By Product (US$ Mn)
TABLE 6. Germany Metagenomics market Revenue And Forecasts to 2025, By application (US$ Mn)
TABLE 7. France Metagenomics market Revenue And Forecasts to 2027, By Product (US$ Mn)
TABLE 8. France Metagenomics market Revenue And Forecasts to 2025, By application (US$ Mn)
TABLE 9. Recent Product Launch in the Metagenomics Market
TABLE 10. Recent Product Approval and Enhancements in the Metagenomics Market
TABLE 11. the Metagenomics Market by Exansion & Others Strategies
TABLE 12. Acquisitions in the Metagenomics Market
TABLE 13. the Metagenomics Market by Agreements
TABLE 14. partnership in the Metagenomics Market
TABLE 15. Glossary of Terms, Metagenomics market
LIST OF FIGURES
FIGURE 1. GErmany Metagenomics market, Revenue (US$ Mn), By 2018 & 2027
FIGURE 2. Europe Metagenomics Market By product, Market Share (%), 2018
FIGURE 3. Europe Metagenomics Market By application, Market Share (%), 2018
FIGURE 4. Metagenomics market Segmentation
FIGURE 5. Europe PEST Analysis
FIGURE 6. Metagenomics market impact analysis of drivers & Restraints
FIGURE 7. Europe Metagenomics market – Revenue Forecasts and Analysis – 2017- 2027
FIGURE 8. Europe metagenomics market By Product, 2018 & 2027 (%)
FIGURE 9. Europe Instruments & software Market Revenue and Forecasts to 2027 (US$ Mn)
FIGURE 10. Europe Consumables Market Revenue and Forecasts to 2027 (US$ Mn)
FIGURE 11. Europe Metagenomics market By application, 2018 & 2027 (%)
FIGURE 12. Europe Clinical Diagnostic Market Revenue and Forecasts to 2027 (US$ Mn)
FIGURE 13. Europe Drug Discovery Metagenomics Market Revenue and Forecasts to 2027 (US$ Mn)
FIGURE 14. Europe Others Market Revenue and Forecasts to 2027 (US$ Mn)
FIGURE 15. Europe Metagenomics Market REVENUE, by Country, 2018 (US$ MN)
FIGURE 16. Europe metagenomics Market Revenue And Forecasts to 2027, By Country (%)
FIGURE 17. UK Metagenomics Market Revenue and Forecasts to 2027 (US$ Mn)
FIGURE 18. Germany Metagenomics Market Revenue and Forecasts to 2027 (US$ Mn)
FIGURE 19. France Metagenomics Market Revenue and Forecasts to 2027 (US$ Mn)
FIGURE 20. Growth Strategies in the Metagenomics Market, 2015-2018
FIGURE 21. Organic Growth Strategies in the METAGENOMICS Market, 2015-2018
FIGURE 22. Inorganic developments in the Metagenomics Market, 2015-2018
The List of Companies
- Merck KGaA
- Thermo Fisher Scientific Inc.
- Agilent Technologies
- Qiagen
- Bio-Rad Laboratories, Inc.
- Perkinelmer Inc.
- Illumina Inc.
- F Hoffman-La Roche Ltd.
- Oxford Nanopore Technologies Ltd.
- Pacific Bioscience of California, Inc.
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the metagenomics market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the global metagenomics market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.